
|Articles|November 15, 2002
Hair Loss Insights
Paris - Results from a series of studies conducted at the Skin Research Laboratory of the Technion-Israel Institute of Technology are providing important insights about the pathogenesis of alopecia areata and a basis for exploring new immunomodulating therapies for the disorder.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
AI at the Bedside: How Automated Solutions are Transforming Vitiligo Management
2
A Patient–Physician Lens on the Real Burden of CHE
3
New Perspectives in Chronic Hand Eczema Care
4
Celldex Advances Barzolvolimab into Phase 3 for Cold Urticaria and Symptomatic Dermographism
5



















